Skip to main content
TipRanks
Go Ultimate75% OFF

Valiant Organics Limited (VALIANTORG) AI Stock Analysis

1 Followers
IN:VALIANTORG

Valiant Organics Limited

(NSE:VALIANTORG)

Select Model
Rating:52Neutral
Price Target:INR 373.00â–²(8.76% Upside)
Action:reiterated
Date:11/06/26

Financial performance weighs most heavily, showing profitability challenges from revenue volatility and recent losses tempered by balance sheet stability and low debt. Technical indicators reflect weakening momentum with price below short-term averages and negative MACD. Valuation offers moderate support via a reasonable P/E.

Positive Factors
Diversified specialty-chemical end marketsExposure across agrochemicals, pharmaceuticals, dyes and pigments, and industrial chemicals gives the company multiple downstream demand pools. This end-market breadth can reduce dependence on any single application and supports a more durable specialty-chemicals platform.
Negative Factors
Multi-year revenue declineA prolonged revenue decline signals pressure on demand, market share, product mix, or pricing power and limits operating leverage. Without a durable return to growth, the company may struggle to spread fixed costs, rebuild margins, and restore its previous earnings scale.

Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)

-50%-25%0%25%50%75%100%IN:VALIANTORG+27.63%INDA-5.96%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 9.48B
Dividend Yield
―
Average Volume (3M)
8,421
Price to Earnings (P/E)
14.6
Beta (1Y)
0.15
Revenue Growth
21.32%
EPS Growth
175.87%
Country
India
Employees
908
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

Valiant Organics Limited Business Overview & Revenue Model

Company Description

Founded in Mumbai, India, in 1984, Valiant Organics Limited operates as a chemical manufacturer, specializing in the production and distribution of specialty chemicals across India. Their diverse product portfolio encompasses a variety of chloropheno...

Valiant Organics Limited Financial Statement Overview

Summary

Mixed results with volatile revenue, recent net losses, and fluctuating margins offset by steady equity growth, low leverage, and recovering positive operating and free cash flows.

Income Statement

35Negative

Balance Sheet

70Positive

Cash Flow

50Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.14B7.39B7.19B7.23B10.52B11.53B
Gross Profit2.90B2.13B2.62B470.01M1.81B2.17B
EBITDA1.24B996.99M615.51M425.75M1.77B2.12B
Net Income657.14M332.36M-37.36M-83.91M881.21M1.13B
Balance Sheet
Total Assets13.35B12.31B11.83B12.48B12.39B11.92B
Cash, Cash Equivalents and Short-Term Investments68.64M21.24M131.53M71.02M456.71M499.47M
Total Debt2.59B2.56B2.49B2.57B2.74B3.63B
Total Liabilities5.29B4.71B4.58B5.19B4.99B5.43B
Stockholders Equity8.06B7.59B7.25B7.29B6.89B6.13B
Cash Flow
Free Cash Flow0439.27M256.03M90.70M862.19M-1.53B
Operating Cash Flow0774.59M564.32M840.00M2.38B-307.47M
Investing Cash Flow0-898.89M-209.61M-649.88M-1.43B-1.24B
Financing Cash Flow071.27M-318.13M-231.19M-1.12B1.67B

Valiant Organics Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price342.95

Price Trends

50DMA412.52Negative
100DMA349.87Negative
200DMA306.13Positive

Market Momentum

MACD-21.24Positive
RSI37.41Neutral
STOCH6.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Negative. The current price of 342.95 is below the 20-day moving average (MA) of 396.79, below the 50-day MA of 412.52, and above the 200-day MA of 306.13, indicating a neutral trend. The MACD of -21.24 indicates Positive momentum. The RSI at 37.41 is Neutral, neither overbought nor oversold. The STOCH value of 6.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VALIANTORG.

Valiant Organics Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IN:VALIANTORG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:NAVINFLUORIN:NAVINFLUOR65NeutralINR 504.83B57.87―0.16%45.68%100.24%
IN:INDIAGLYCOIN:INDIAGLYCO64NeutralINR 18.23B5.50―0.95%12.01%23.71%
IN:INDOAMININ:INDOAMIN62NeutralINR 8.18B10.15―0.44%22.17%1.86%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IN:DEEPAKNTRIN:DEEPAKNTR56NeutralINR 216.86B20.07―0.48%25.13%99.89%
IN:PUNJABCHEMIN:PUNJABCHEM55NeutralINR 10.81B17.89―0.34%13.95%15.36%
IN:VALIANTORGIN:VALIANTORG52NeutralINR 9.61B14.64――21.32%175.87%

* Basic Materials Sector Average

Performance Comparison

-25%0%25%50%75%IN:VALIANTORGIN:DEEPAKNTRIN:INDIAGLYCOIN:INDOAMININ:NAVINFLUORIN:PUNJABCHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:VALIANTORG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:VALIANTORGValiant Organics Limited342.9571.4526.32%
IN:DEEPAKNTRDeepak Nitrite Limited1561.25-136.15-8.02%
IN:INDIAGLYCOIndia Glycols Limited271.9535.5115.02%
IN:INDOAMINIndo Amines Limited112.70-14.29-11.25%
IN:NAVINFLUORNavin Fluorine International Limited10260.004293.1471.95%
IN:PUNJABCHEMPunjab Chemicals & Crop Protection Ltd.881.60-481.92-35.34%

Valiant Organics Limited Corporate Events

Valiant Organics posts Q1 FY27 results, renews MD and shifts registered office

Aug 12, 2026

Valiant Organics Limited’s board has approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following audit committee review, and will publish these figures in accordance with securities regulations. The...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026